Chemoprevention of oral cancer: Green tea experience
Open Access
- 1 January 2014
- journal article
- review article
- Published by Manuscript Technomedia LLP in Journal of Natural Science, Biology and Medicine
- Vol. 5 (1) , 3-7
Abstract
Oral cancer has a well characterized progression from premalignant oral epithelial changes to invasive cancer, making oral squamous cell carcinoma an optimal disease for chemoprevention interventions prior to malignant transformation. The primary goal of chemoprevention here is to reverse, suppress, or inhibit the progression of premalignant lesions to cancer. Due to the extended duration of oral pathogenesis, its chemoprevention using natural products has been found promising due to their decreased dose and limited toxicity profiles. This review discusses with an emphasis on the clinical trials using green tea extract (GTE) in chemoprevention of oral premalignant lesions along with use of GTE as a chemopreventive agent in various other cancers as well. It is worthwhile to include green tea extract in an oral screening program for evaluating the premalignant lesions comparing the results between the treated and untreated group. Given the wide acceptance of green tea, its benefits may help in effective chemoprevention oral cancer.Keywords
This publication has 46 references indexed in Scilit:
- Phase II Randomized, Placebo-Controlled Trial of Green Tea Extract in Patients with High-Risk Oral Premalignant LesionsCancer Prevention Research, 2009
- Natural products and colon cancer: current status and future prospectsDrug Development Research, 2008
- (-)-Epigallocatechin Gallate Regulates CD3-mediated T Cell Receptor Signaling in Leukemia through the Inhibition of ZAP-70 KinaseJournal of Biological Chemistry, 2008
- Green tea catechins inhibit angiogenesis through suppression of STAT3 activationBreast Cancer Research and Treatment, 2008
- SHP-2 tyrosine phosphatase inhibits p73-dependent apoptosis and expression of a subset of p53 target genes induced by EGCGProceedings of the National Academy of Sciences, 2007
- Epigallocatechin-3-gallate Inhibits Epidermal Growth Factor Receptor Signaling PathwayJournal of Biological Chemistry, 2004
- Apoptosis Induction by Epigallocatechin Gallate Involves Its Binding to FasBiochemical and Biophysical Research Communications, 2001
- Low-Dose Isotretinoin Versus -Carotene to Prevent Oral Carcinogenesis: Long-term Follow-upJNCI: Journal of the National Cancer Institute, 1997
- Selective-Inhibition of Steroid 5 α-Reductase Isozymes by Tea Epicatechin-3-Gallate and Epigallocatechin-3-GallateBiochemical and Biophysical Research Communications, 1995
- 13-cis-Retinoic Acid in the Treatment of Oral LeukoplakiaNew England Journal of Medicine, 1986